The results showed that HCC patients with elevated FBXL19-AS1 had shorter overall survival (p = 0.030) (Figure 4B), hinting FBXL19-AS1 might be an important prognostic factor for HCC. This evidence concerns the gene FBXL19 and hepatocellular carcinoma.